BRIANA MCMORRIS: Open Payments
NPI 1841870292 · MALTA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 60 payments from 16 companies in 2025. Trend: 2023 $1,114 · 2024 $1,186 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $277 |
| Axsome Therapeutics, Inc. | 10 | $227 |
| ABBVIE INC. | 12 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $137 |
| Lundbeck LLC | 4 | $92 |
| Alkermes, Inc. | 3 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Novo Nordisk Inc | 1 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
Products named: CAPLYTA, Auvelity, VRAYLAR, TRINTELLIX, REXULTI, ARISTADA, INGREZZA, Wegovy.
Industry payments across NY — which companies pay providers there.
